Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Triple Negative Breast Neoplasms
×
niraparib
×
Clear all
Filters
3
NCT01042379
2026-03-13
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2
Recruiting
5,000 enrolled